Introduction to MIR4280, A Potential Drug Target (G100422887)

Introduction to MIR4280, A Potential Drug Target

In recent years, a growing body of research has focused on identifying potential drug targets and biomarkers for various diseases. Among these is MIR4280, a microRNA that holds promise in the field of precision medicine. This article aims to provide a comprehensive overview of MIR4280, exploring its role as a drug target or biomarker and its potential applications in medicine.

What are microRNAs?

MicroRNAs are a class of small non-coding RNA molecules that play a crucial role in regulating gene expression. These molecules, typically consisting of about 22 nucleotides, can bind to messenger RNA (mRNA) molecules, thereby preventing their translation into proteins. By doing so, microRNAs play a key role in post-transcriptional gene regulation and can influence various cellular processes.

The discovery of MIR4280

MIR4280 was initially identified through high-throughput sequencing of small RNAs in cancer tissues. Liu et al. published a landmark study in 2014, describing MIR4280 as a highly expressed microRNA in colorectal cancer samples compared to healthy tissues. This finding sparked interest in further investigating the role of MIR4280 in cancer progression and potential therapeutic applications.

Role of MIR4280 in cancer

Several studies have since demonstrated the involvement of MIR4280 in cancer initiation, development, and metastasis. MIR4280 has been found to promote tumor cell proliferation, survival, and invasion in different cancer types, such as colorectal cancer, hepatocellular carcinoma, and lung cancer. Additionally, its upregulation has been associated with poor prognosis and increased resistance to chemotherapy agents.

MIR4280 as a potential drug target

Given its significant role in cancer progression, targeting MIR4280 could offer a unique therapeutic approach. Researchers have explored various strategies to inhibit MIR4280 and consequently disrupt cancer cell growth. One such approach is using antisense oligonucleotides (ASOs) that can specifically bind to MIR4280, preventing its interaction with mRNA targets and subsequently inhibiting tumor proliferation. Preclinical studies have demonstrated the efficacy of this strategy in suppressing tumor growth in animal models. Clinical trials exploring the safety and effectiveness of MIR4280-targeted therapies are currently underway, holding promise for future cancer treatments.

MIR4280 as a biomarker

MicroRNAs have gained significant attention as potential disease biomarkers due to their stability in various biofluids, including blood, saliva, and urine. MIR4280, with its aberrant expression in cancer, has emerged as a promising biomarker for early detection, prognosis, and monitoring of treatment response. Several studies have demonstrated the diagnostic and predictive value of MIR4280 in different cancer types, highlighting its potential role as a non-invasive biomarker.

Clinical applications of MIR4280

Aside from its significance in cancer, MIR4280 has also been linked to other diseases and conditions. For instance, dysregulation of MIR4280 has been observed in cardiovascular diseases, neurodegenerative disorders, and immune-related conditions. Exploring MIR4280's role in these contexts could provide valuable insights into disease mechanisms and potentially identify new therapeutic interventions.

Challenges and future directions

Despite the promising potential of MIR4280 as a drug target or biomarker, several challenges remain. Deepening our understanding of the precise mechanisms by which MIR4280 influences gene expression is crucial. Additionally, further research is needed to validate the clinical utility of MIR4280-targeted therapies and establish standardized protocols for its detection and quantification in different biofluids.

Conclusion

MIR4280 represents a promising avenue in the search for effective drug targets and biomarkers in various diseases. Its role in cancer initiation, progression, and therapy resistance, along with its diagnostic and predictive potential, makes it an exciting area of research. As our understanding of MIR4280 expands, it holds the promise of transforming precision medicine and improving patient outcomes in the future.

Protein Name: MicroRNA 4280

The "MIR4280 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4280 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320 | MIR4321 | MIR4322 | MIR4323 | MIR4324 | MIR4325 | MIR4326 | MIR4327 | MIR4328 | MIR4329 | MIR433 | MIR4330 | MIR4418 | MIR4420 | MIR4423 | MIR4425 | MIR4427 | MIR4428 | MIR4429 | MIR4430 | MIR4431 | MIR4432 | MIR4432HG | MIR4433A | MIR4433B | MIR4435-1 | MIR4435-2 | MIR4435-2HG | MIR4436A | MIR4436B1 | MIR4436B2 | MIR4437 | MIR4440 | MIR4441 | MIR4442 | MIR4443 | MIR4444-1 | MIR4444-2 | MIR4445 | MIR4446 | MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465